Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zimu Wang

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Translational Lung Cancer Research|August 2, 2019
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysisZimu Wang, Ping Zhan, Yanling Lv, et al.
Medical Oncology (Northwood, London, England)|July 14, 2022
c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancerZimu Wang, Yicong Huang, Wanjun Lu, et al.
Scientific Reports|January 21, 2025
Sustainable application of waste gangue mortar in coal mine tunnel supportYang Liu, Luming Zhu, Xijun Liang, et al.
International Immunopharmacology|May 6, 2026
Targeting the RNA acetyltransferase NAT10 attenuates pulmonary fibrosis via the ac4C-mediated regulation of the C/EBPβ-ITGA11 axisZimu Wang, Qiuxia Wu, Yu Yao, et al.
Biomarker Research|June 11, 2021
Metastasis-associated fibroblasts: an emerging target for metastatic cancerZimu Wang, Jiaxin Liu, Hairong Huang, et al.
BMC Medicine|November 7, 2022
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic reviewYimin Wang, Chuling Li, Zimu Wang, et al.
Molecular Biomedicine|January 4, 2026
Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implicationChaofu Li, Zimu Wang, Yukun Yang, et al.
Signal Transduction and Targeted Therapy|January 22, 2021
Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathwaysJiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Therapeutic Advances in Medical Oncology|July 6, 2026
CD39+CD8+ T cell infiltration is associated with clinical outcomes of subsequent immunotherapy in advanced EGFR-mutant non-small cell lung cancerWanjun Lu, Qiuxia Wu, Zimu Wang, et al.
Biochemical and Biophysical Research Communications|November 12, 2019
LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblastsJiateng Sun, Zimu Wang, Haojie Shi, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Translational Lung Cancer Research|August 2, 2019
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysisZimu Wang, Ping Zhan, Yanling Lv, et al.
Medical Oncology (Northwood, London, England)|July 14, 2022
c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancerZimu Wang, Yicong Huang, Wanjun Lu, et al.
Scientific Reports|January 21, 2025
Sustainable application of waste gangue mortar in coal mine tunnel supportYang Liu, Luming Zhu, Xijun Liang, et al.
International Immunopharmacology|May 6, 2026
Targeting the RNA acetyltransferase NAT10 attenuates pulmonary fibrosis via the ac4C-mediated regulation of the C/EBPβ-ITGA11 axisZimu Wang, Qiuxia Wu, Yu Yao, et al.
Biomarker Research|June 11, 2021
Metastasis-associated fibroblasts: an emerging target for metastatic cancerZimu Wang, Jiaxin Liu, Hairong Huang, et al.
BMC Medicine|November 7, 2022
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic reviewYimin Wang, Chuling Li, Zimu Wang, et al.
Molecular Biomedicine|January 4, 2026
Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implicationChaofu Li, Zimu Wang, Yukun Yang, et al.
Signal Transduction and Targeted Therapy|January 22, 2021
Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathwaysJiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Therapeutic Advances in Medical Oncology|July 6, 2026
CD39+CD8+ T cell infiltration is associated with clinical outcomes of subsequent immunotherapy in advanced EGFR-mutant non-small cell lung cancerWanjun Lu, Qiuxia Wu, Zimu Wang, et al.
Biochemical and Biophysical Research Communications|November 12, 2019
LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblastsJiateng Sun, Zimu Wang, Haojie Shi, et al.
Pageof 5